

CLASSIFICATION: FAT BURNING PEPTIDE FRAGMENT
ACTIVE SUBSTANCE: AOD 9604
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 4–6 HOURS
DOSAGE: 300–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
Peptide Hubs AOD 9604 5 mg is a lab-tested peptide fragment of human growth hormone (HGH) designed to stimulate fat burning without affecting blood sugar levels. Each 2 mL vial contains 5 mg of AOD 9604, formulated to pharmaceutical standards for research purposes.
AOD 9604 (Advanced Obesity Drug) is a modified fragment of the human growth hormone molecule (specifically amino acids 176–191). It has been shown to promote lipolysis (fat breakdown) and inhibit lipogenesis (fat formation), making it a promising agent for weight management research [Clinical Study].
Research protocols typically involve subcutaneous administration of 300–500 mcg once or twice daily. Best results are observed when combined with an active lifestyle and calorie control. Professional supervision is recommended for all peptide research studies.
Complement fat loss research by combining AOD 9604 with CJC-1295 DAC by Dragon Pharma. View more advanced peptides in the Peptide Hubs USA category.
AOD 9604 is used in research to promote fat breakdown, support weight loss, and prevent the accumulation of new fat without affecting blood glucose regulation.
Common research protocols involve administering 300–500 mcg subcutaneously once or twice daily. Dosing may vary based on study goals and individual response.
AOD 9604 has shown a strong safety profile in clinical studies, being non-diabetogenic and well-tolerated. Professional supervision is recommended for all research use.
Authentic AOD 9604 5 mg can be ordered from our Peptide Hubs USA section, offering premium lab-tested peptides.
Please log in to write AOD 9604 5 MG review.